home / stock / sght / sght news

SGHT News and Press, Sight Sciences Inc. From 08/06/23

Stock Information
Company Name: Sight Sciences Inc.
Stock Symbol: SGHT
Market: NASDAQ
Website: sightsciences.com
Menu
SGHT SGHT Quote SGHT Short SGHT News SGHT Articles SGHT Message Board
Get SGHT Alerts

News, Short Squeeze, Breakout and More Instantly...
SGHT - Sight Sciences, Inc. (SGHT) Q2 2023 Earnings Call Transcript

2023-08-06 07:32:09 ET Sight Sciences, Inc. (SGHT) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Philip Tailor - Investor Relations Paul Badawi - Co-Founder & Chief Executive Officer Ali Bauerlein - Chief Financial Officer ...
SGHT - Sight Sciences GAAP EPS of -$0.30 beats by $0.06, revenue of $23.5M beats by $1.11M

2023-08-03 17:31:08 ET Sight Sciences press release ( NASDAQ: SGHT ): Q2 GAAP EPS of -$0.30 beats by $0.06 . Revenue of $23.5M (+36.4% Y/Y) beats by $1.11M . Sight Sciences reaffirms revenue guidance expectations for the full year 2023 of $89.0 million to $94.0...

SGHT - Sight Sciences Reports Second Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023

MENLO PARK, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today reported finan...

SGHT - XXII, GP and ACGN among mid-day movers

2023-07-21 13:09:38 ET Gainers: Digital World Acquisition Corp. ( DWAC ) +47% . Quoin Pharmaceuticals ( QNRX ) +46% . 22nd Century Group ( XXII ) +41% . Guardforce AI Co ( GFAI ) +28% . Biodexa Pharmaceuticals Plc ( BDRX ) +25% ....
SGHT - Sight Sciences to Report Second Quarter 2023 Financial Results on August 3, 2023

MENLO PARK, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today announced it will report financial result...

SGHT - Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA, a Randomized Controlled Clinical Trial Comparing Interventional Eyelid Procedures Enabled by TearCare® Technology to Restasis¹ for the Treatment of D

MENLO PARK, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients...

SGHT - Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy)

Cigna has close to 15 million covered lives Cigna’s Coverage Policy includes procedures enabled with OMNI ® Surgical System technology as medically necessary and covered MENLO PARK, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: S...
SGHT - Sight Sciences Announces Addition of New Director Catherine Mazzacco

MENLO PARK, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today an...

SGHT - IONQ, BIG and MBOT among mid-day movers

2023-06-02 13:27:06 ET Gainers: LAVA Therapeutics N.V. ( LVTX ) +79% . U Power Limited ( UCAR ) +34% . Samsara ( IOT ) +30% . MongoDB ( MDB ) +27% . Digital Ally ( DGLY ) +26% . iHeartMedia ( IHRT ) +24% . The Che...

SGHT - Sight Sciences: Recent Stock Price Pullback Is Unwarranted

2023-05-30 17:00:54 ET Summary Sight Sciences, Inc.'s share price has fallen by -13.3% in the past 3 weeks, despite reporting a narrower-than-expected net loss in Q1 and sticking to its 2023 guidance. Sight Sciences' key Q1 2023 metrics offered positive read-throughs for the compa...
Previous 10 Next 10